Atlas Trials

An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)

Clinical trial NCT00449111 · TERMINATED

Trial details

NCT number
NCT00449111
Sponsor
Organon and Co
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension
Start date
2006-03-13
Primary completion
2006-09-30
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.